Where America’s vaccine triumph fell short
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Monday
January 30, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
MONDAY, JANUARY 30, 2023
Where America’s vaccine triumph fell short

Analysis

Scott Duke Kominers, Bloomberg
11 April, 2021, 06:45 pm
Last modified: 11 April, 2021, 06:50 pm

Related News

  • Holiday trips within China surge after lifting of Covid curbs
  • India launches world’s 1st intranasal Covid vaccine
  • US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot
  • China says Covid deaths down by nearly 80 percent
  • Updated Covid vaccines prevented illness from latest variants -CDC

Where America’s vaccine triumph fell short

In a crisis, Washington should fully embrace its many strengths, and also those of the private sector

Scott Duke Kominers, Bloomberg
11 April, 2021, 06:45 pm
Last modified: 11 April, 2021, 06:50 pm
A public-private victory that should go down in U.S. history.  Photographer: Ulrich Baumgarten/Getty Images
A public-private victory that should go down in U.S. history. Photographer: Ulrich Baumgarten/Getty Images

It's not surprising that pharmacies are turning out to be fantastic at distributing Covid-19 vaccines. As Alex Tabarrok and I pointed out in February, they are literally everywhere — 86% of the US population lives within 5 miles of one. And they have significant experience in large-scale vaccine delivery, giving out 40-50 million flu vaccines annually. 

But the success of pharmacies raises an important question about another part of the effort: the federally-run mass vaccination sites. 1 Managed by FEMA, staffed by the National Guard and flush with federal funds, they are underperforming the Biden administration's expectations, according to Politico.

There's a broader lesson here about how the government can combine its strengths with those of the private sector to deliver for its citizens during crises and beyond.

When it comes to committing enormous amounts of capital to provide public goods — like developing vaccines as quickly as possible — the US government is hard to match. That's what it did with Operation Warp Speed, putting over $10 billion into vaccine development and production, and securing manufacturing and pricing commitments that ensured Americans would benefit from any of the vaccine bets that paid off.

The government can also use its authority to get firms working towards a shared goal. In the past few months, the Biden administration has helped coordinate supply chains for vaccines and the manufacturing of personal protective equipment. It also brokered a vaccine production collaboration between competing pharmaceutical manufacturers Merck & Co., Inc. and Johnson & Johnson. (There remains more work to do in this area. As my collaborators and I have argued, existing capacity for both producing vaccine ingredients and manufacturing the vaccines themselves is far below the optimal level.)

The federal government is also well-positioned to set standards for ensuring orderly, transparent and equitable access to public resources — such as figuring out how to stage the vaccine rollout across different groups.

Unfortunately, however, the prior administration mostly left that task to states, leading to inconsistent — and sometimes heavily politicized — vaccine allocation processes. National-level guidance on priority groups, coupled with provider subsidies to ensure equitable access, should have been clear from the outset.

America's Covid-19 response has also suffered from a lack of centralized standards for the vaccination process itself. The government could have provided technology recommendations for appointment registration and eligibility verification, or developed a platform that distribution partners could plug into. Instead, we've ended up with a patchwork of appointment mechanisms — many of them quite difficult to navigate. 2 It's so complicated and chaotic that talented individuals have stepped in to help.

Meanwhile, as the vaccine mega-site experiment shows, the government can struggle to build distribution infrastructure from scratch, at least when compared to existing players in the market. Pharmacies and other medical offices already had the facilities, the staff and the trust and awareness of consumers. But doses that could have been allocated more efficiently through pharmacies and other local institutions were tied up in the mega-sites instead.

This disorganized approach to public-private partnership isn't limited to pharmacies and vaccines. Covid-19 testing and tracking has suffered from similar inability to leverage existing infrastructure and coordinate guidelines and standards.

Beyond established players like pharmaceutical firms (in the context of Warp Speed) and pharmacies (in the context of vaccine delivery), the government should be looking for ways to work with upstarts. A growing number of marketplace platforms are building supplier networks nationwide. DoorDash, for example, just started offering Covid-19 tests on-demand. Amazon, meanwhile, is experimenting with a large-scale telehealth initiative.

The government could support these efforts — and might even imagine building upon them for other forms of public service delivery in the future. With a flexible enough regulatory framework, delivery services could one day help manage and distribute food aid. Telehealth providers could dramatically expand public health care access.

There's a lot of opportunity here, but only if the government learns to lean on existing service providers to the greatest extent possible. As the nation gets close to turning the corner on vaccine delivery, it shouldn't forget how it got there.

  1. These are distinct from the state-run mass vaccination sites, although some of those have had uneven performance as well.

  2. Of course, there's a benefit to experimenting with different scheduling and registration technologies, but at present there's no way to integrate and scale the ones that work best.


Scott Duke Kominers is the MBA Class of 1960 Associate Professor of Business Administration at Harvard Business School, and a faculty affiliate of the Harvard Department of Economics. Previously, he was a junior fellow at the Harvard Society of Fellows and the inaugural research scholar at the Becker Friedman Institute for Research in Economics at the University of Chicago.

Disclaimer: This article first appeared on bloomberg.com, and is published by special syndication arrangement.

Coronavirus chronicle / Top News

America / Vaccine / COVID-19

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Collected
    Economic slump drags down growth in VAT collection from big cos
  • It's corruption that bites business harder: CPD
    It's corruption that bites business harder: CPD
  • Import slowdown to affect economic growth: ADB country head
    Import slowdown to affect economic growth: ADB country head

MOST VIEWED

  • Getting gas to India will be even more costly than laying this pipe to China.Photographer: Andrey Rudakov/Bloomberg
    Russia can't replace the energy market Putin broke
  • Illustration: TBS
    Biz leaders want crisis management, energy security for survival
  • A proper price formula can help investors to plan big
    A proper price formula can help investors to plan big
  • SK Bashir Uddin: TBS sketch
    Investments risky without consistent policy, reliable data
  • Shams Mahmud. TBS Sketch
    Lack of coordination, policy biggest problems
  • TBS Talk: What Lies Ahead
    TBS Talk: What Lies Ahead

Related News

  • Holiday trips within China surge after lifting of Covid curbs
  • India launches world’s 1st intranasal Covid vaccine
  • US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot
  • China says Covid deaths down by nearly 80 percent
  • Updated Covid vaccines prevented illness from latest variants -CDC

Features

Nandita Sharmin's journey to give organic skincare a new identity

Nandita Sharmin's journey to give organic skincare a new identity

11h | Mode
Illustration: TBS

'The silver lining is that the worst is sort of behind us': Hamid Rashid, UN economist

15h | Panorama
Photo: Bloomberg

BuzzFeed and AI are a match made in fad city

14h | Panorama
Snipe in flight. Photo: Enam Ul Haque

Baikka Beel: 'A world where snipe work late'

1d | Panorama

More Videos from TBS

Sarika Sabrin is waiting for a good film

Sarika Sabrin is waiting for a good film

5h | TBS Entertainment
Take your football game to the next level at Next Level academy

Take your football game to the next level at Next Level academy

6h | TBS SPORTS
“Investments risky without consistent policy, reliable data”- SK Bashir Uddin

“Investments risky without consistent policy, reliable data”- SK Bashir Uddin

7h | TBS Round Table
What does Shahrukh has in his 770 million dollar property?

What does Shahrukh has in his 770 million dollar property?

1d | TBS Entertainment

Most Read

1
Picture: Collected
Bangladesh

US Embassy condemns recent incidents of visa fraud

2
Illustration: TBS
Banking

16 banks at risk of capital shortfall if top 3 borrowers default

3
Photo: Collected
Splash

Hansal Mehta responds as Twitter user calls him 'shameless' for making Faraaz

4
A frozen Beyond Burger plant-based patty. Photographer: AKIRA for Bloomberg Businessweek
Bloomberg Special

Fake meat was supposed to save the world. It became just another fad

5
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

6
Representational Image
Banking

Cash-strapped Islami, Al-Arafah and National turn to Sonali Bank for costly fund

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]